Thiazolidinediones, a class of anti-diabetic drugs, inhibit Id2 expression through a PPARγ-independent pathway in human aortic smooth muscle cells

Cellular and Molecular Life Sciences

Volumn 60, Issue 1, 2003, Pages 212-218

  Zhu, X ^a,b   Lin, Y ^b   Zhang, J ^b   Fu, M ^b   Mao, Z ^a   Chen, Y E ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Diabetes; Gene expression; Proliferation; Vascular smooth muscle cell

Indexed keywords

2 [1 CARBOXY 2 [4 [2 (5 METHYL 2 PHENYL 4 OXAZOLYL)ETHOXY]PHENYL]ETHYLAMINO]BENZOIC ACID METHYL ESTER; 2 CHLORO 5 NITROBENZANILIDE; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; CIGLITAZONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ANTAGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RECEPTOR BLOCKING AGENT; THIAZOLIDINE DERIVATIVE; TROGLITAZONE; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; DEFENSE MECHANISM; DIABETES MELLITUS; DNA BINDING; DNA SYNTHESIS INHIBITION; DOWN REGULATION; DRUG INHIBITION; GENE EXPRESSION; HUMAN; MUSCLE GROWTH; NONHUMAN; NUCLEOTIDE SEQUENCE; SMOOTH MUSCLE FIBER; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE;

ANILIDES; AORTA; CHROMANS; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GENE EXPRESSION REGULATION; HUMANS; HYPOGLYCEMIC AGENTS; INHIBITOR OF DIFFERENTIATION PROTEIN 2; MUSCLE, SMOOTH, VASCULAR; OXAZOLES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REPRESSOR PROTEINS; RNA, MESSENGER; THIAZOLES; THIAZOLIDINEDIONES; TIME FACTORS; TRANSCRIPTION FACTORS; TYROSINE;

EID: 0037278026     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180300015     Document Type: Article

References (19)

1. Olefsky J. M. and Saltiel A. R. (2000) PPAR gamma and the treatment of insulin resistance. Trends Endocrinol. Metab. 11: 362-368
2. Kersten S., Desvergne B. and Wahli W. (2000) Roles of PPARs in health and disease. Nature 405: 421-424
3. Olefsky J. M. (2000) Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists. J. Clin. Invest. 106: 467-472
4. Bishop-Bailey D., Hla T. and Warner T. D. (2002) Intimal smooth muscle cells as a target for peroxisome proliferator-activated receptor-gamma ligand therapy. Circ. Res. 91: 210-217
5. Law R. E., Goetze S., Xi X. P., Jackson S., Kawano Y., Demer L. et al. (2000) Expression and function of PPARgamma in rat and human vascular smooth muscle cells. Circulation 101: 1311-1318
6. Moore K. J., Rosen E. D., Fitzgerald M. L., Randow F., Andersson L. P., Altshuler D. et al. (2001) The role of PPAR-gamma in macrophage differentiation and cholesterol uptake. Nat. Med. 7: 41-747
7. Chawla A., Barak Y., Nagy L., Liao D., Tontonoz P., Evans R. M. et al. (2001) PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat. Med. 7: 48-52
8. Lennon A. M., Ramauge M., Dessouroux A. and Pierre M. (2002) MAP kinase cascades are activated in astrocytes and preadipocytes by 15-deoxy-delta(12-14)-prostaglandin J(2) and the thiazolidinedione ciglitazone through peroxisome proliferator activator receptor gamma-independent mechanisms involving reactive oxygenated species. J. Biol. Chem. 2002 277: 29681-29685
9. Fu M., Zhang J., Zhu X., Myles D. E., Willson T. M., Liu X. et al. (2001) Peroxisome proliferator-activated receptor gamma inhibits transforming growth factor beta-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with Smad3. J. Biol. Chem. 276: 45888-45894
10. Yokota Y. and Mori S. (2002) Role of Id family proteins in growth control. J. Cell Physiol. 190: 21-28
11. Norton J.D., Deed R.W., Craggs G. and Sablitzky F. (1998) Id helix-loop-helix proteins in cell growth and differentiation. Trends Cell Biol. 8: 58-65
12. Norton J. D. (2000) ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J. Cell Sci. 113: 3897-3905
13. Iavarone A., Garg P., Lasorella A., Hsu J. and Israel M. A. (1994) The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein. Genes Dev. 8: 1270-1284
14. Matsumura M. E., Lobe D. R. and McNamara C. A. (2002) Contribution of the helix-loop-helix factor Id2 to regulation of vascular smooth muscle cell proliferation. J. Biol. Chem. 277: 7293-7297
15. Willson T. M., Brown P. J., Sternbach D. D. and Henke B. R. (2000) The PPARs: from orphan receptors to drug discovery. J. Med. Chem. 43: 527-550
16. 2 inhibits PDGF-A and -B chain expression in human vascular endothelial cells independent of PPARγ. Biochem. Biophys. Res. Commun. 298: 128-132
17. Mueller C., Baudler S., Welzel H., Bohm M. and Nickenig G. (2002) Identification of a novel redox-sensitive gene, Id3, which mediates angiotensin II-induced cell growth. Circulation 105: 2423-2428
18. Matsumura M. E., Li F., Berthoux L., Wei B., Lobe D. R., Jeon C. et al. (2001) Vascular injury induces posttranscriptional regulation of the Id3 gene: cloning of a novel Id3 isoform expressed during vascular lesion formation in rat and human atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 21: 752-758
19. Davies G. F., Khandelwal R. L., Wu L., Juurlink B. H. and Roesler W. J. (2001) Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: a peroxisome proliferator-activated receptor-gamma (PPARgamma)-independent, antioxidant-related mechanism. Biochem. Pharmacol. 62: 1071-1079